ABBV
64
-4
TGNA
70
-2
PRGO
46
-4
CPB
32
-13
CB
44
-3
CHD
51
-2
MRK
40
-5
HSIC
54
-2
SWKS
40
-2
PSA
50
-5
RF
63
5
AIG
78
-2
LB
62
-7
LMT
29
-21
UHS
59
-4
EXR
40
-6
L
60
8
JNJ
56
5
NTAP
37
2
LUV
62
-8
ABBV
64
-4
TGNA
70
-2
PRGO
46
-4
CPB
32
-13
CB
44
-3
CHD
51
-2
MRK
40
-5
HSIC
54
-2
SWKS
40
-2
PSA
50
-5
RF
63
5
AIG
78
-2
LB
62
-7
LMT
29
-21
UHS
59
-4
EXR
40
-6
L
60
8
JNJ
56
5
NTAP
37
2
LUV
62
-8
Financhill
Back

Mineralys Therapeutics 10K Form

Buy
70

MLYS
Mineralys Therapeutics

Last Price:
$16.87
Seasonality Move:
-0.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLYS News And Ratings

See the #1 stock for the next 7 days that we like better than MLYS

MLYS Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-66.8M
Price / Cash Flow: 0
Annual Sales: $3.84
Price / Book: 5.54

Profitability

EPS (TTM): -3.64000
Net Income (TTM): $-177.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Mineralys Therapeutics Earnings Forecast

Key Mineralys Therapeutics Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 1 years.

Mineralys Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MLYS
Website: mineralystx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MLYS Technical Analysis vs Fundamental Analysis

Buy
70
Mineralys Therapeutics (MLYS) is a Buy

Is Mineralys Therapeutics a Buy or a Sell?